Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS-CoV-2 (COVID-19) Severe Pneumonia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04416139
What this trial is testing

Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19

Who this might be right for
Covid 19
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 10
Not applicableUnknownNCT04681755
What this trial is testing

Rehabilitation Required Due to Clinical Disorders After Severe Covid-19 Infection

Who this might be right for
Covid19
University Hospital, Strasbourg, France 55
Early research (Phase 1)Study completedNCT05548439
What this trial is testing

Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a

Who this might be right for
COVID-19Coronavirus Infections
VBI Vaccines Inc. 103
Testing effectiveness (Phase 2)Study completedNCT04760730
What this trial is testing

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
R-Pharm 100
Testing effectiveness (Phase 2)UnknownNCT05741099
What this trial is testing

Application and Research of Mesenchymal Stem Cells in Alleviating Severe Development of COVID-19 Infection

Who this might be right for
COVID-19
Hebei Medical University 20
Testing effectiveness (Phase 2)UnknownNCT04397497
What this trial is testing

Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)

Who this might be right for
Covid-19Acute Respiratory FailureARDS, Human+2 more
Ospedale San Raffaele 50
Not applicableStudy completedNCT05234359
What this trial is testing

The CHILD Cohort COVID-19 Add-On Study

Who this might be right for
SARS-CoV InfectionCovid19
University of Manitoba 5,385
Large-scale testing (Phase 3)UnknownNCT04321616
What this trial is testing

The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients

Who this might be right for
SARS-CoV InfectionCOVID 19Acute Respiratory Distress Syndrome ARDS
Oslo University Hospital 700
Not applicableStudy completedNCT04998799
What this trial is testing

Practice Variation on Antithrombotics in COVID-19

Who this might be right for
COVID-19 PneumoniaThrombosisCOVID-19 Acute Respiratory Distress Syndrome+1 more
NMC Specialty Hospital 435
Testing effectiveness (Phase 2)Study completedNCT04590547
What this trial is testing

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

Who this might be right for
PneumonitisSARS-CoV Infection
GeneOne Life Science, Inc. 132
Not applicableStudy completedNCT05263908
What this trial is testing

Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19

Who this might be right for
SARS-CoV-2 Infection
Pfizer 3,346
Large-scale testing (Phase 3)UnknownNCT04656613
What this trial is testing

A Phase III Clinical Trial of the Immunogenicity and Safety of the Gam-COVID-Vac Vaccine Against COVID-19 in the UAE

Who this might be right for
Covid19SARS-CoV Infection
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 1,000
Not applicableStudy completedNCT04644159
What this trial is testing

Longitudinal Follow-up of a Population Cohort in a French City With High SARS-CoV-2 Circulation, in Early 2020 [COVID-19]

Who this might be right for
SARS (Severe Acute Respiratory Syndrome)Covid19
Institut Pasteur 1,000
Early research (Phase 1)Study completedNCT04482686
What this trial is testing

Trial of Combination Therapy to Treat COVID-19 Infection

Who this might be right for
COVIDCovid-19Corona Virus Infection+4 more
ProgenaBiome 31
Not applicableNo Longer AvailableNCT04355494
What this trial is testing

SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19

Who this might be right for
COVID-19Pneumonia, ViralAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Alexion Pharmaceuticals, Inc.
Not applicableLooking for participantsNCT05890612
What this trial is testing

A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19

Who this might be right for
COVID-19
Pfizer 3,000
Not applicableNo Longer AvailableNCT04646031
What this trial is testing

Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19

Who this might be right for
Covid19
Tasly Pharmaceuticals, Inc.
Not applicableStudy completedNCT04349202
What this trial is testing

Beaumont Health Large-scale Automated Serologic Testing for COVID-19

Who this might be right for
COVID-19Coronavirus InfectionSevere Acute Respiratory Syndrome Coronavirus 2
Corewell Health East 20,614
Not applicableLooking for participantsNCT05835102
What this trial is testing

Influence of Nutritional Indices on the Prognosis of Patients With SARS-CoV-2 Infection

Who this might be right for
COVID-19
Juan Kang 800
Not applicableLooking for participantsNCT07781501
What this trial is testing

Long-Term Study of COVID-19 Infection and Long COVID

Who this might be right for
SARS CoV-2 Post-Acute Sequelae
University of North Carolina, Chapel Hill 500
Next Page